1. Without any preventive measures, 1 in ____ black men who have sex with men (MSM) will contract human immunodeficiency virus (HIV) in their lifetimes?

2. TM recently found out that one of the men he had sex with in the last 4 months has tested positive for HIV. You begin a conversation with him to discuss HIV prevention and determine whether he is a candidate for preexposure prophylaxis (PrEP). TM tells you that he is often the receptive partner during anal sex. He is interested in starting PrEP, and asks, “How long does it take until the PrEP medicine is working?”

How many days does it take to reach maximally protective levels in rectal tissue?

3. JH, who has been injecting drugs for 5 years, comes to the pharmacy on Tuesday afternoon. She is worried that she might have been exposed to HIV. While answering your risk-assessment, she explains that on Friday evening she shared needles with someone she did not know very well. On Tuesday morning, a woman told her, “Everyone knows that guy has HIV.”

Based on CDC guidelines for postexposure prophylaxis (PEP) initiation, do you recommend PEP for JH?

4. Which antiretroviral PEP regimen is included in the Centers for Disease Control and Prevention (CDC) guidelines, but NOT approved for use under Colorado State Board of Pharmacy (SBOP) Rule 17?

5. Which of the following accurately reflects CDC guidelines for HIV screening?

6. BK is a 32-year-old heterosexual woman who suspects that her partner is bisexual and having sex with men. She is upset about this and requests information on PrEP. Which of the following antiretroviral regimens is appropriate for use as PrEP by individuals whose mode of HIV exposure is vaginal receptive sex?

7. TL is an MSM who has been on PrEP for 2 years; he consistently returns to the pharmacy for guideline-based, interval monitoring. What laboratory test do you perform every 3 months?

« Return to Activity